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ABSTRACT  
Objective: The aim of this study, we based on protective and antioxidant efficiency of Hypericum perforatum that shows a wide range of beneficial 
effect in vitro and in vivo. 
Methods: The in vitro antioxidant activity of the extract was assessed by using several antioxidant tests. The cytotoxic activity of Hypericum 
perforatum was also determined by using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide viability assay on ordinary used cell lines. 
In vivo experiments in Swiss mice were determined by performing behavioral, memory tests and histological study. According to tests results, H. 
perforatum may be relevant to the treatment of cognitive disorders. 
Results: The results of chemical analysis showed a hight level of hyperforin and quercitin that had an important antioxidant activity proved in vitro 
with the 2, 2-diphenyl-1-picrylhydrazyl, Anti-lactoperoxidase and superoxide dismutases; this antioxidant activity was confirmed in vivo after the 
non-toxic results by means of improvement in behavioral and memory than the reducing shrunken in pyramidal cells of mice brains.  
Conclusion: The present study suggests that Hypericum perforatum modulate the oxidative stress and be involved in the protective effect against 
oxidative damage and neurodegenerative diseases in mice. 
Keywords: Neurotoxicity, Alzheimer’s disease, Phytotherapy, Hypericum perforatum, Neuroprotective, Mice 
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INTRODUCTION 
Alzheimer's disease (AD) is a multifactorial disease, complex, and 
progressive affecting the older population the most observed 
dementia cases is in persons over 65 y of age [1, 2]. 
Histological and pathological studies of AD have revealed that 
multiple cellular pathways are involved in AD progression [3]. The 
pathological features identified in the central nervous system (CNS) 
in AD are amyloid plaques, neurofibrillary tangles, inflammatory 
processes and disturbance of neurotransmitters [4, 5]. The 
dysfunction and degeneration of synapses in AD may involve Aβ-
induced oxidative stress compromises the mitochondrial function by 
an oxidative-stress-mediated mechanism [6]. 
Reactive oxygen species (ROS) are produced by many redox 
processes that normally occur in the metabolism of aerobic cells. 
These species are very reactive and harmful to the cells. If not 
eliminated, ROS can damage vital molecules, such as proteins, DNA, 
and lipids. Cells express several defense mechanisms, including 
antioxidant enzymes and non-enzymatic compounds that help 
prevent the damaging effects of ROS [7]. 
Oxidative stress can also play an important role in the development 
of neurodegenerative disorders, such as Alzheimer’s and Parkinson’s 
diseases [8, 9]. There is an increasing interest in natural 
antioxidants, namely the phenols, present in medicinal and dietary 
plants, that might help prevent oxidative damage. [10-14]. In 
situations of increased free radical generation, the reinforcement of 
endogenous antioxidants via intake of dietary antioxidants may be of 
particular importance in attenuating the cumulative effects of 
oxidatively damaged molecules. In recent years, the consumption of 
Hypericum perforatum (St. John’s wort) derived products have 
increased dramatically, and presently it is one of the most consumed 
medicinal plants over the world [15]. The commercially available H. 
perforatum derived products include sophisticated 
phytopharmaceuticals and nutraceuticals, teas, tinctures, juices and 
oil macerates [16]. H. perforatum has a wide range of medicinal 
applications, including skin wounds, eczema, burns, diseases of the 
alimentary tract and psychological disorders. Nowadays, its use in 
the treatment of mild to moderate depression has become 
prominent [17-19]. Numerous papers have been published 
concerning these aspects and several recent reviews can be pointed 
out [19-21]. In spite of this intense research activity, the antioxidant 
potential of H. perforatum extracts has been somewhat neglected. 
Current studies suggested that H. perforatum possessed protective 
effects against H2O2
The chemical composition of the Hypericum species is composed of 
naphthodianthrones (especially hypericin and pseudo hypericin), 
acylphloroglucinol derivatives (especially hyperforin and 
adhyperforin), flavonoids (especially quercetin, quercitrin, 
hyperoside and biapigenin), tannins, n-alkanes, xanthones and 
essential oils. [18, 23, 24]  
 induced apoptosis of PC12 cells than might be 
useful in the treatment of oxidative stress related to 
neurodegenerative diseases such as Alzheimer disease [22]. 
The aim of this study was to identify the potential of H. perforatum 
as a protective and therapeutic agent against neurodegenerative 
disorders and Alzheimer's disease.  
The chemical composition of ethanolic extract of H. perforatum was 
analyzed by using HPLC-DAD. In order to determine the antioxidant 
potential of H. perforatum, was evaluated by employing several 
antioxidant tests. The cytotoxic activity of the extract was also 
determined by using MTT cell cytotoxicity screening assay on HeLa 
and NRK-52E cell lines. The in vivo studies on Swiss male mice were 
determined by utilizing behavioral, memory tests and histological 
analysis. 
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This represents the first report on the chemical composition, 
antioxidant, cytotoxic and anti-Alzheimer activity of H. perforatum 
that has been tested in this study. 
MATERIALS AND METHODS 
Plant and animals 
Aerial parts of H. perforatum were collected in Malatya (Turkey) in 
June 2010. The plant material was identified by Şükran Kültür and a 
voucher specimen (ISTE 93192), was deposited in the Herbarium of 
the University Of Istanbul Faculty Of Pharmacy, Istanbul, Turkey. 
The ethanol extracts were obtained by maceration of the plant 
material with ethanol for 3 d at room temperature and this 
procedure currently was repeated twice. The respective extracts 
were filtered and dried under reduced pressure at a temperature 
below 218.15 K. The crude methanol extract was lyophilized and 
stored at 153.15 K. 
The in vivo studies were performed on Swiss mice (3-month-old), 
22-26g, purchased from Pasteur Institute of Algiers. Mice were 
housed in the Laboratory animal care of Mostaganem University in 
12-hour light-dark cycles at 196.15 K with free access to food and 
water. 
Chemical agents 
Hypericin, chlorogenic acid, rutin, hyperoside, isoquercitrin, 
quercitrin, kaempferol, quercetin, amentoflavone, hyperforin, AlCl3
Nitrobluetetrazolium (NBT), β-nicotinamide adenine dinucleotide 
reduced (NADH), soybean L-α-phosphatidylcholine Type IV-S, 
butylated hydroxytoluene (BHT), 3-(2-pyridyl)-5,6-bis (4-phenyl-
sulfonic acid)-1,2,4-triazine (ferrozine), rutin and catechin were 
purchased from Fluka Chemical Co. (Buchs, Switzerland). 
Phenazinemethosulphate (PMS), 2,2-diphenyl-1-picryl-hydrazyl 
(DPPH•), ethylene diamine tetraacetic acid (EDTA), Gallic acid and 
ascorbic acid were obtained from Sigma Chemical Co. (St. Louis, MO, 
USA). Potassium ferric cyanide, trichloroacetic acid (TCA), 
thiobarbituric acid (TBA), ferrous and ferric chloride were obtained 
from Merck. All other reagents were of analytical grade. 
 
and D-Galactose were obtained from Sigma-Aldrich (Taufkirchen, 
Germany). Pseudohypericin was trained from PhytoPlan 
(Heidelberg, Germany). Milli-Q ultrapure water was obtained from 
Millipore (Billerica, MA), HPLC grade acetonitrile, methanol, ethyl 
acetate and sodium dihydrogen phosphate dihydrate were obtained 
from Merck (Darmstadt, Germany) and orthophosphoric acid 85% 
was obtained from Fluka (Steinheim, Switzerland).  
The 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) reagent were purchased from Sigma (St. Louis, 
USA). Dimethylsulfoxide (DMSO), trypsin (Biomatik, Canada), 
absolute alcohol, ethylene diamine tetraacetic acid (EDTA), sodium 
hydroxide (Merck, Germany). Fetal bovine serum (FBS), 
Dulbecco’s Modified Eagle Medium (DMEM), penicillin-
streptomycin, phosphate buffer saline (PBS) were purchased from 
Multicell-Wisent Inc. (Quebec, Canada). Cytotoxicity detection kit 
(LDH) which containing catalyst, dye solution and stop solution 
were purchased from Roche (Mannheim. Germany). All other 
reagents were of analytical grade. 
Experiment 1 
The dried flowering aerial parts of H. perforatum were macerated in 
ethanol for 3 d at room temperature and the resulting extract was 
filtered through Whatman No.1. The residue from the filtration was 
extracted again twice having the same procedure. The filtrates 
obtained were combined and then evaporated to dryness under 
reduced pressure at a temperature below 318.15 K. The crude 
methanol extract was lyophilized and stored at 253.15 K [25, 26]. 
Extracts prepared with this procedure were used in the HPLC 
analysis and biological activity studies. 
The extract has been tested by HPLC-DAD. The HPLC system 
consisted of a Shimadzu 10A model (Shimadzu Analytical and 
Measuring Instruments, Kyoto, Japan), a pump (LC-10AD), a diode-
array detector (DAD) (SPD-M10A) and an autosampler (SIL-10AD).  
Separation was accomplished with an ACE C18 column, 250 x 4.6 
mm i.d., 5 µm (Advanced Chromatography Technologies, Alberdeen, 
Scotland). The elution conditions were as follows: flow rate: 1 
cm3/60s; column temperature: 313.15 K; injection volume: 0.01 cm3
The solvent system used was a gradient of solvent A (0.3% formic 
acid in water (v/v)) and solvent B (0.3% formic acid in aceto-nitril 
(v/v)) to identify and quantify phenolic compounds and hyperforin 
(European Pharmacopoeia, 2008). The following gradient was 
applied: 0–1080 s, 82% A; 480–1080 s, 82–47% A; 1080–1086 s, 47–
3% A; 1086–1740 s, 3% A; 1740–2400 s, 3–82% A. The solvent 
system used was an isocratic of solvent A (Ethyl acetate: 15.6 g/dm
; 
detection: 590 nm for pseudo-hypericin and hypericin, 360 nm for 
phenolic compounds and 275 nm for hyperforin. 
3
The control of the system and the data analysis procedure was 
performed with Shimadzu LC Solutions software.  
 
sodium dihydrogen phosphate adjusted to pH: 2 with phosphoric 
acid: methanol/39:41:160/v/v/v) to identify and quantify pseudo-
hypericin and hypericin (European Pharmacopoeia, 2008). All 
solvents were filtered through 0.45 µm filters prior to use and 
degassed in an ultrasonic bath. 
The calibration curves were prepared with external standards 
solution within the different concentration range in methanol. The 
experiment was performed for three times providing the same 
conditions. The calibration curves were constructed by using the 
average of peak areas.  
The crude ethanol extract was dissolved in a mixture of methanol/ 
water (8:2, v/v). All samples were filtered through 0.45 µm filters 
into a vial for HPLC analysis. Each sample was prepared and injected 
for three times. 
Experiment 2 
In vitro antioxidant activity 
Total soluble phenolic in the methanolic extracts was determined 
with Folin-Ciocalteu reagent according to the method of Slinkard & 
Singleton with some modifications [27]. 
The amount of total phenolic compounds was calculated from the 
calibration curve of Gallic acid standard solution (covering the 
concentration range between 0.05 and 0.4 mg/ml) and expressed as 
mg Gallic acid equivalents (GAE)/g dry weight (DW) of the plant 
material. 
Total flavonoid content was established by using a method 
described by Sakanaka [28]. Total flavonoid contents were 
calculated based on the calibration curve prepared with standard 
catechin solution and expressed mg of (+)-catechin equivalents (CE) 
per g of DW of the plant material. 
The DPPH radical scavenging activity of the methanolic extracts was 
measured according to the procedure described by Brand-Williams 
[28]. Two controls were utilized for this test, a negative control 
(containing all reagents except the test sample) and positive controls 
(using the reference antioxidants). The ability to scavenge DPPH 
radical was calculated by the following equation:  
AA (DPPH radical scavenging activity %) =  �(1 −Abs  sample )517nm
(Abs  control )517nm
� Χ 100  
Lipid peroxidation (LPO) assay was prepared on the basis of the 
method described by Duh et al. and Brand-Williams et al. [39-30]. 
Formation of LPO products was assayed by the measurement of 
malondialdehyde (MDA) levels on the basis of MDA reacted with 
TBA at 532 nm according to Buege & Aust. The percentage inhibition 
of LPO was calculated by comparing the results of the sample with 
those of controls not treated with the extract using the following 
equation:  
Inhibition effect (%) =  �1 −  Abs sample
532nm
Abs
control (532nm)� Χ 100 
The effect of the ethanolic extract on the generation of superoxide 
radicals was determined by the nitro blue tetrazolium (NBT) 
reduction method of Nishikimi [29]. Abilities to scavenge the 
superoxide radical were calculated by comparing the results of the 
Zerrouki et al. 
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sample with those of controls not treated with the extract using the 
following equation:  
SOD scavenging (%)  =  [1
−  Abs sample (560nm)/Abs control (560nm)] Χ 100 
FRAP assay was carried out in accordance with the procedure of 
Benzie & Strain [31-33]. The standard curve was constructed using 
iron sulphate heptahydrate solution (125-2000 µM), and the results 
were reported in mm Fe2+
In vitro cytotoxic activity 
equivalents.  
Cytotoxicity of the extract at various concentrations was determined 
on human cervix adenocarcinoma (HeLa, ATCC CCL-2) and 
normal rat kidney epithelial (NRK-52E, ATCC
The results were generated from three independent experiments; 
each experiment was performed in triplicate. 
 CRL-6509) cell 
lines by the MTT assay, which is widely used for the measurement of 
cell viability. Briefly, the cells were seeded in 96-well plates at a 
density of 104 cells/well in 100 μl culture medium. Following 24-h 
incubation and attachment, the cells were treated with different 
concentrations of plant extracts and controls for 24 h. Dry 
methanolic extracts were dissolved in dimethyl sulphoxide (DMSO) 
as a solvent to obtain appropriate stock solutions of the extracts. 
Dilution of stock extracts of solutions was made in serum-free 
medium yielding final extracts concentrations from 0.125 to 2 
mg/ml. DMSO and 5-fluorouracil (5-FU) were used solvent and 
positive controls, respectively The concentration range used for 5-
FU was 50 to 1000 μm. The yellow MTT dye was reduced by succinic 
dehydrogenase in the mitochondria of viable cells to purple 
formazan crystals. The absorbance was measured by a microplate 
reader (BioTek, USA) at 570 nm with a reference wavelength of 670 
nm. The reduction of absorbance was evaluated the inhibition of 
enzyme activity observed in cells compared to untreated (negative 
control) cells. Then, the half maximal inhibitory concentration 
(IC50) was expressed as the concentration of the sample caused an 
inhibition of 50% in enzyme activities in cells as flows [34].  
IC % = 100 − [(mean absorbance of extract x100)
/mean absorbance of solvent control] 
Experiment 3 
In vivo experimental design included three groups of mice 
Control group: Mice were administered freshwater orally and served 
as normal control. Alzheimer’s model group: Mice were treated with 
AlCl3 (100 mg/kg/day) concomitant with IP D-Gal in order of 120 
mg/kg, respectively (1.5*10-6 cm3
Treated Alzheimer’s model group: Received concomitant with the 
Alzheimer’s dose, 0.1 cm
/s).  
3
Both H. perforatum and chemical (ALCl
 IP of H. perforatum in order of 200 
mg/kg/day. The experiment lasted 3 mo.  
3
Behavioral and memory tests 
& D-Gal) were dissolved in 
distilled water in order to be administered for the needed dose. 
The different groups were monitored for the onset of postural 
abnormalities, general behavioral changes memory and learning.  
Locomotors activity refers to the movement from one location to 
another. In rodents, one of the most important components of 
exploration, a prominent activity of the rat’s repertoire of impulsive 
activity, is locomotion. We detected spontaneous motor activity over 
a four periods of 1200 s (300 s each) in an activity cage. Measure of 
motor exercise endurance was evaluated using a divided box 
apparatus counting the number of visited cases. 
The anxiety test was established by means of dark/white connected 
rooms. The light/dark test is built on the innate aversion of rodents 
to brightly illuminated areas and on the spontaneous exploratory 
behavior of rodents in response to mild stressors, that is, novel 
environment and light. The test apparatus consists of a small 
obscure safe compartment (half box) and a large floodlit aversive 
compartment. Mice are placed in one of the rooms and the time 
spent in each room was assessed. These tests were realized during 
1200 s divides to four phases, 300 s each.  
The hole board test was used to assess the behavior of mice 
confronted with a new environment. The test is to determine the 
effects of psychotropic drugs on exploratory behavior exhibited by 
the animal. It only takes a few minutes and does not require learning 
or conditioning of animals from them. Exploration holes movements 
are counted as a score of exploration. 
The study of memory incorporates research methodologies from 
neuropsychology, human development and animal testing using a 
wide range of species. 
Understanding memory has benefited greatly from animal research. 
Animal’s brains can be selectively lesions using neurotoxic methods 
(AlCl3
Non-spatial memory was used in neurology in order to assess 
memory disorder depends upon the hippocampus. For this aim of 
the experiment, only two arms of the maze were utilized. A baited 
lighted arm and the other arm were unlit. The subject is well placed 
on the central platform with two closed arms, and the two arms are 
straight successively for it to adapt to its new environment. The 
spending time in the lighted arm was assessed. 
 in this case) and be assessed comparatively to the treated 
mice. The assessment of animal memory utilizing different types of 
mazes has been largely used in neurosciences. Several models have 
been proposed recently, mainly trying to evaluate the accuracy of 
choice between the alternatives presented in the same day of the 
session, instead of looking for the accumulated learning through 
successive days of training. 
Working memory relates to a short-term memory system used to 
complete a task, such as a relationship between objects and 
locations. To demonstrate that mice were matched for memory 
ability after the treatment period, working memory was evaluated in 
averaging the reentries and error entries, respectively, for the 
successive days of experimentation. 
Histological study 
Histological, analyses were performed on formalin-fixed and 
paraffin-embedded brain tissues from the experiment’s treatment 
groups. Briefly, whole formalin-fixed brains were cut in 2 nm thick 
slices along the sagittal plane and embedded in formalin. 2 mm thick 
serial sections were stained with Haematoxylin-Eosin, periodic acid 
Schiff, Luxol fast blue and Perls’ stain. 
Statistical analysis  
About in vivo studies, the data are expressed as means with SEM The 
statistical significance of differences between groups was assessed 
with an analysis of variance followed by Student Newman-Keuls. A P 
value of 0.05 or less was considered as a criterion for a statistically 
significant difference.  
RESULTS  
Experiment 1 
The LC chromatograms of the ethanolic extract of H. perforatum 
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Fig. 1: It shows the LC chromatogram of ethanolic extract of H. 
perforatum A: Pseudohypericin (1), hypericin (2) in the extract 
at 590 nm (fig. 1A) B: Chlorogenic acid (1), rutin (2), hyperoside 
(3), isoquercitrin (4), quercitrin (5), kaempferol (6), quercetin 
(7), amentoflavone (8) in the extract at 360 nm (fig. 1B) C: 
Hyperforin (1) in the extract at 275 nm (fig. 1C) 
 
Experiment 2 
In vitro antioxidant activity 
In table  2 and table 3. 
 
In vitro cytotoxic activity 
Ethanolic extract of H. perforatum was evaluated for in vitro 
cytotoxic activity using the colorimetric MTT assay in HeLa and 
NRK-52E cell lines. The IC50 value (mg/cm3
Experiment 3: In vivo study 
) is given in the table. The 
extract did not demonstrate significant cytotoxic activity against 
HeLa and NRK-52E cell lines. 
Behavioral tests  
The performance of mice in the step-through passive avoidance 
training and testing shows a remarkable difference between 
Alzheimer treated, and the Alzheimer’s model groups; 
locomotors activity test showed a hyperactivity in Alzheimer’s 
model group comparatively to the treated Alzheimer’s and 
control groups.  
Anxiety tests presented in this study with the dark and light rooms, 
showed significant results for the treated Alzheimer’s comparatively 
to the Alzheimer’s model group. 
The test of maze plus was assessed by the time spending in a 
covered arm squares noted as score per time of 1200 s, 300 s each 
phases showed high activity for the Alzheimer’s treated 
comparatively with the Alzheimer’s model group. fig. 2. 
Memory tests 
Non-spatial memory test preferably conditional results obtained 
during the five experimental tests show that Alzheimer’s model 
mice spent shortly time in the arm lit unlike treated Alzheimer’s 
and control mice, that put a very short time to get informed on the 
arm. 
For the work spatial memory, the results of the treated Alzheimer’s 
group was very significant and very close to the control group 
results in the last experiment day comparatively to the Alzheimer’s 
model group. fig. 3. 
 
Table 1: it shows the chemical compounds of the extract found in HPLC chromatogram 
Compounds Retention time (min) Calibration equation values Linear regression (r2 H. perforatum (yield, %) ) 
Pseudohypericin 4.86 y= 2.582269e+007x+1741.874 0.9998 0.075±0.0100 
Hypericin 13.93 y= 6.03411e+007x+297.2292 0.9999 0.067±0.0400 
Chlorogenic acid 4.33 y= 5110294x+1490.398 0.9999 0.008±0.0010 
Rutin 8.89 y= 1.383368e+007+5188.182 0.9999 1.015±0.0400 
Hyperoside 10.19 y= 2.849917e+007x+526.7023 0.9999 0.491±0.0900 
Isoquercitrin 10.75 y= 1.671137e+007x–3712.788 0.9999 0.389±0.0600 
Quercitrin 14.41 y= 1.205178e+007–3518.974 0.9999 0.135±0.0100 
Kaempferol 17.09 y= 5.183916e+007x+4373.856 0.9999 0.002±0.0001 
Quercetin 17.84 y= 3.688175e+007+18905.43 0.9999 0.125±0.0050 
Amentoflavon 20.27 y= 2.207879e+007+772.0972 0.9996 0.006±0.0002 
Hyperforin 27.75 y= 6212343x 0.9997 3.375±0.5000 
 
Table 2: it shows the total extractable compounds (EC), total phenolic compounds (PC) (As Gallic acid equivalents) and total flavonoids 
(as catechin equivalents) in the extract 
Extracts  EC (mg/g DWa PC (mg/g DW) a Flavonoid (mg/g DW) a) 
H. perfoatum 267.8 34.7 ± 0.9 31.8 ± 0.9 
DW: Dried Weight 
 
Table 3: it shows the antioxidant activity (EC50
Extracts  
 values) 
Average of EC50 (mg/ml) 
Anti-LPO DPPH Superoxide Reducing power 
H. perforatum 2.74 ± 0.19 0.27 ± 0.12 1.38 ± 0.09 0.29 ± 0.02 
Quercetin 0.059 ± 0.001 0.064 ± 0.001 0.461 ± 0.014 0.045 ± 0.008 
*Values were the means of three replicates ± standard deviation. 
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Table 4: It shows the cytotoxic potential of the extract (IC50 
value) 
 IC50 values (mg/ml) 
Extracts HeLa NRK-52E  
H. perforatum 0.541 0.619 





Fig. 2: Shows the result of behavioral test; A: Locomotors 
activity of Alzheimer’s model mice (Alz) intoxicated by AlClз 
(100 mg/kg Oral+0,1 cmP3 P IP of D-Galactose 120 mg/kg), 
Alzheimer’s treated (Alz. T) by Hypericum Perforatum (200 
mg/kg) 0,1 cmP3 P IP, and the control (Control) without any 
treatment; for 90 d. B: Anxiety/curiosity test of Alzheimer’s 
model mice (Alz), Alzheimer’s treated (Alz. T), and the control 
(Control); for 90 d. C: curiosity test of Alzheimer’s model mice 
(Alz), Alzheimer’s treated (Alz. T), and the control (Control) for 
90 d. (*) Significant result for Alz. T group compared to the 
control in the three behavior tests: P<0.05 
 
Histological studies 
H&E staining shows that there are typical neuropathological changes 
in the cerebral cortex and hippocampus of Alzheimer’s model. In the 
control groups, the neurons were full and arranged tightly; the 
nuclei were lit stained. By comparison in the model group mice the 
cytoplasm of neuron were shrunken, the nuclei were side moved and 
dark stained, neurofibrillary degeneration and neurone loss were 
observed in the hippocampus. Hypericum perforatum administration 
showed moderated neuropathological changes. The treatment 
decreased the shape modifications of the neurons, with prolonged 
neurofibrillary reactions. fig. 4. 
DISCUSSION 
A complex mixture of bioactive secondary metabolites in several 
Hypericum species makes them valuable as herbal drugs [35-37]. H. 
perforatum (Common St. John’s wort), certainly the best known and 
worldwide the most abundant representative, is today the most 
investigated species of the genus [38]. Since the early 90’s, H. 
perforatum has been clinically studied from the perspective both of 
its chemical constituency and of its biological activity [39]. Around 
2500 studies on Hypericum have been published to date (thereof c. 
950 without H. perforatum; S. Crockett, pers. com.), including several 
reviews focused on the phytochemistry of H. perforatum [38,40-41], 
its pharmacology [42,44] or both aspects [38,45-47]. 
Phytochemical analysis of H. perforatum was achieved for the first 
time in this work; it was investigated the medicinal value of H. 
perforatum. According to European Pharmacopoeia, H. perforatum is 
a traditional medicinal plant with antidepressive and antioxidant 
properties. It contains a large number of constituents with 
documented biological activity including phenolic, a broad range of 
flavonoids and bioflavonoids, hypericin, adhyperforin, 
amentoflavone, hyperoside and isoquercitrin [47]. The chemical 
compounds of H. perforatum are provided in table 1. A total of 11 
components were defined in the extract. Hyperforin constituted the 
major fraction (3.375%) this is due to the fact that hyperforin is 
photosensitive and its highest concentrations appear just before the 
blossom period [48]. 
It has been determined that hyperforin, a major constituent of H. 
perforatum, inhibits the proliferation of epithelial cells and human 
peripheral blood mononuclear cells, even when stimulated by phyto-
hemagglutinin. Furthermore, another study [49], also justified the 
anticancer activity of extracts of H. perforatum by the presence of 
hyperforin and hypericin of the plant. Previous work [50] De Freitas 
Silva et al. demonstrated that compounds other than hypericin are 
highly relevant for both radical scavenging and inhibition of lipid 
peroxidation activities. 
Rutin constituted the second major fraction, accounting for 1.015% 
of the extract. Umek et al. found that the content of rutin in H. 
perforatum was in a strong positive correlation with the altitude of 
the growing site, opposite to the quercitrin content [51]. 
Chlorogenic acid has been reported to inhibit lipid peroxidation by 
scavenging peroxyl radicals, thereby preventing the initiation of 
chain lipid peroxidation [50]. Also, chlorogenic acid had been 
reported to be an effective scavenger against peroxyl radicals [50]. 
According to the previous research [52], Chlorogenic acid has an 
effective antioxidant activity. These data are in accordance with the 
recently published chemical characterization of H. perforatum of 
Macedonia [48].  
In the present study, using various in vitro experiments, we found 
that H. perforatum markedly inhibited XO activity, suggesting that 
besides direct scavenging [53,54]; inhibition of the XO enzyme may 
contribute to the scavenging action of the OR2RP- Pradical by H. 
perforatum.  
Considering antioxidant activity of the marine sponge species 
screened herein; the literature survey indicated that there has been 
only one former study describing the antioxidant potential of the 
compounds; 2-octaprenyl-1,4-hydroquinone and 2-(24-hydroxy)-
octaprenyl-1,4-hydroquinone isolated from I. spinosula and its eight 
synthetic derivatives [55]. Their antioxidant activity was tested in 
vitro by scavenging of free radical DPPH and inhibition of the lipid 
peroxidation induced by the FeP++P/ascorbate system. Two natural 
hydroquinone derivatives were found to display high antioxidant 
effect in both tests, which was in accordance with our results. In our 
DPPH radical scavenging assay, the highest scavenging effect 
(65.92%) was observed in I. variability of Antalya-I collection (table 
3) and linear terpenes including. 
C 
C 
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Fig. 3: Shows the result of memory test A: Non-spatial memory test preferably conditional of Alzheimer’s model mice (Alz) intoxicated by 
AlClз (100 mg/kg Oral+0,1 cm3 IP of D-Galactose 120 mg/kg), Alzheimer’s treated (Alz. T.) by Hypericum Perforatum (200 mg/kg) 0,1 
cm3
 
IP, and the control (Control) without any treatment; for 90 d, B: work spatial memory test of Alzheimer’s model mice (Alz), 
Alzheimer’s treated (Alz. T.), and the control (Control); for 90 d. (*) Significant result for Alz. T. group compared to the control in memory 
tests: (P<0.05) 
 
Fig. 4: It shows the microscopic study of Cerebral cortex and 
Hippocampus performed by staining (HE) in model Alzheimer’s 
mice (Alz) induced by AlCl3 orally (100MG/KG)+0,1 cm3 IP of D-
Galactose (120 mg/Kg), treated Alzheimer’s model mice (Alz. T) 
with Hypericum perforatum for three months with 0,1 cm3
 
 
IP(200 mg/Kg) (T) compared to cerebral cortex & hippocampus 
of control mice (G × 400). (Alz) cerebral cortex characterized by 
a decrease in cell density and neuronal degenerative and 
vacuolization (G × 400), (Alz. T) shows a decrease of edema and 
vacuolization in treated Alzheimer’s (G × 400) (■)Low cell 
density; (◄  ) Vacuolization 
 The extract showed the DPPH radical scavenging activity in a dose-
dependent manner. The results show that at 2.5 mg/cm3 the extract 
(31.80±0.9%), did not differ in their DPPH radical scavenging 
activities (p > 0.05), which were comparable to that of quercetin 
(96.89 ± 0.72 %) at 0.31 mg/cm3. Our results were in agreement 
with previous research [56] that reported the similar DPPH radical 
scavenging activity of 91.3% and 82.6% for H. scabroides and H. 
triquetrifolium, respectively. It was reported that H. perforatum 
extract showed relatively high DPPH radical scavenging effect with 
an average IC50 value of 10.63 µg/cm3
The inhibition of Fe (III) and ascorbic acid-induced lipid 
peroxidation assay results revealed that the extract inhibited TBARS 
formation and destruction of phospholipid in a concentration-
dependent manner. The highest antioxidant activity of the extract 
was observed in high concentration (5 mg/cm
 [57]. It was evident that H. 
perforatum, H. triquetrifolium and H. scabroides extracts had 
stronger effects on the DPPH radicals compared to HSM used in this 
study. It can be explained with the different phytochemical 
composition. It is known that only flavonoids of a certain molecular 
structure, particularly those with a certain hydroxyl position will 
determine the antioxidant properties [58].  
3). The antioxidant 
activity of the extract was determined lower than quercetin activity. 
Based on the EC50 values, the antioxidant activity of HPM was 
significantly lower (p<0.05) with an EC50 value of 2.74 ± 0.219 
mg/cm3in comparison with quercetin (0.059 ± 0.001 mg/cm3). 
Although the inhibitory effect of the extract on TBARS formation was 
less than that of quercetin, the extract may also be supposed to 
protect against damage to cell membranes, because it also reduces 
the level of peroxides. However, the extract has the capacity to 
remove free radicals and inhibit lipid peroxidation. The results 
consistent with the other in vitro studies with Hypericum species. 
Couladis and Silva et al. have reported that the methanolic extract of 
H. perforatum shown to inhibit lipid peroxidation with an EC50 value 
of 26 µg/cm3 [59,60]. It is reported that the methanolic extract of H. 
perforatum shown to inhibit (70%) lipid peroxidation [57]. It was 
also reported by Kızıl et al. that the extracts obtained from H. 
triquetrifolium and H. scabroides showed high potential to inhibit 
lipid peroxidation [56]
The extract was found to be an efficient scavenger of superoxide 
radical generated in PMS/NADH system, and its superior activity 
was comparable (p>0.05) to that of quercetin. Both extract and 
quercetin exhibited dose-dependent inhibition of superoxide radical.  
. 
The reducing power of the extract was found to be correlated with 
increasing absorbance (at 700 nm) as compared with quercetin. The 
extract has shown the potential of reducing ferric (III) form of iron 
to ferrous (II). These results compared with previous studies, similar 
results were reported for H. triquetrifolium and H. scabroides [56].  
Antioxidant activity of the extract was examined by using four 
different methods. Table 3 shows EC50
There was a great correlation between total phenolic contents and 
reductive potential and lipid peroxidation inhibitory activity. As a 
result, this extract has antioxidant activity due to the phenolic 
compounds have the potential to act as antioxidants by scavenging 
free radicals, reducing power and blocking the formation of peroxide 
radicals and reducing power. 
 values of the extract in 
antioxidant properties. The differences of the results explained 
diverse mechanisms of oxidative stress. 
Since the cytotoxic activity potential of the extracts having 
antioxidant activity is an important parameter, the cytotoxic activity 
of the HeLa and NRK-52E cell lines is investigated. The results reveal 
that the extracts have no cytotoxic activity. 
Antidepressant activity of H. perforatum is certainly the main reason 
for the general public’s enthusiasm for this herbal medication [43]. 
The classical use of (dried alcoholic) extracts of H. perforatum for the 
treatment of mild to moderate depression has been demonstrated to 
be effective in several trials and meta-analyses, in the same citation 
the antidepressant activity of H. perforatum-based formulations can 
be attributed to several classes of secondary metabolites, which 
Zerrouki et al. 
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exhibit additive, synergetic and partly antagonistic effects [61,42]. 
According to the actual state of scientific knowledge, the total 
extracts must be considered as the active principle [41].  
The effects of H. perforatum on the central nervous system were 
investigated using various behavioral and memory models, including 
locomotors activity, dark/lighted rooms and hole-board for the 
behavior assessment, non-spatial memory and worked spatial 
memory for the memory experiments. According to the results, it 
was found that extracts prepared from H. perforatum were effective 
as anti-depressant drug. This conclusion suggested that the anti-
depressant effects of H. perforatum were remarkable in behavioral 
tests and may be used for therapeutic purposes in depression [62]. 
The species (rodents) in which aluminum-induced neurobehavioral 
effects (e. g., changes in locomotors activity, learning, and memory) 
have been observed fail to develop significant cytoskeletal pathology, 
but exhibit a number of neurochemical alterations following in vivo or 
in vitro exposure [63, 64]. In this case, the locomotors activity 
decreased in treated Alzheimer’s comparatively to the Alzheimer’s 
group that confirms that hyperactivity observed for the Alzheimer’s 
group could be the result of stress conditions [65].  
Anxiety-related behavior is measured as a preference for the closed 
arms [66-68]. The percentage of open arm entries also indicates 
anxiety levels, especially in mice, which tend to be more impulsive 
and spend less time per entry in any arm. In this study, the time 
spent in opens area and close to the control group. The hole-board 
test provides a simple method for measuring the response of an 
animal to an unfamiliar environment and is widely used to assess 
emotionality, anxiety and/or responses to stress [69-71].  
After the treatment administration of both Aluminum and 
Hypericum the head dip counts decreased without changing in 
locomotion. These results indicate that H perforatum has satisfactory 
in anxiolytic effect in this paradigm [72]. After “training” an 
experimental animal, such as a mouse, the only way to be sure that a 
“memory” was formed is by evoking it back, i.e., by recalling it in a 
“test” session: this “memory” is expressed by a behavior that differs 
from that one emitted in the training session. Training sessions 
consist of repeating a number of trials, several days in a row (4-8 
trials a day, for 2 to 5 d-or more, when training to a criterion) [73]. 
Non-spatial memory conditional preference showed an 
improvement from the third day as same as the work spatial 
memory that improved from the 4Th day, that result confirm the 
damage reduction in the brain in treated Alzheimer’s comparatively 
to the Alzheimer group.  
More specifically, the entire brain of patients with Alzheimer’s 
disease (AD) was shown to be subjected to an oxidative challenge 
[74]. In addition, overall peroxidation activity in brains of AD 
patients was significantly elevated compared to normal subjects 
[75]. In the reverse phenomena, H. perforatum extract contains 
flavonoids such as rutin, quercetin, and quercitrin, which 
demonstrated a free radical scavenging activity in a model of auto-
oxidation of rat cerebral membranes [76].  
In this investigation, the effect of H. perforatum lead to a reduction of 
neurotoxicity and Alzheimer's disease appeared as shrunken 
decreased in pyramidal cells, reduced effect of the decreasing number 
of the pyramidal cells. These brain moderation changes inducing by H. 
perforatum Alzheimer’s were due to reducing oxidative damage and 
edema which contribute to disease pathogenesis and were in 
accordance with some researchers research [77].  
CONCLUSION  
Operative treatments and medications are still absent to seize 
Alzheimer’s diseases. AD is a progressive neurodegenerative 
disorder that affects the elderly population particularly. Since 
pathogenesis of AD has not been clarified totally, yet, it is only a 
symptomatic treatment available. The most prescribed drug class 
against AD is cholinesterase inhibitors, which increase the level of 
acetylcholine/butyryl-choline in the brain. 
Another factor contributing to the pathology of neurodegenerative 
diseases is oxidative stress, which leads to neuronal death. 
Inflammation is also linked to neurodegeneration by diverse 
mechanisms such as accretion of proteins with abnormal 
conformations or via signals emanating from injured neurons. 
Considering the herbal treatment, we initiated an intensive research 
on the neuroprotective activity of the H. perforatum through the 
enzyme inhibition linked to neurodegeneration and antioxidant 
activity methods, which have so far let us to realize the in vitro and 
in vivo studies. 
Antioxidant activity of the samples has been tested in a number of 
tests such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), N,N-dimethylp-
phenylenediamine (DMPD), superoxide, nitric oxide, hydrogen 
peroxide104 radical scavenging, ferric-reducing antioxidant power 
(FRAP), and phospho-molybdenum reducing antioxidant power 
(PRAP) assays and confirmed by in vivo study showing a decrease in 
cell degeneration. 
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